129 related articles for article (PubMed ID: 15767789)
1. The oncogenic potential of hepatitis C virus NS5A sequence variants is associated with PKR regulation.
Giménez-Barcons M; Wang C; Chen M; Sánchez-Tapias JM; Sáiz JC; Gale M
J Interferon Cytokine Res; 2005 Mar; 25(3):152-64. PubMed ID: 15767789
[TBL] [Abstract][Full Text] [Related]
2. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
Gale M; Kwieciszewski B; Dossett M; Nakao H; Katze MG
J Virol; 1999 Aug; 73(8):6506-16. PubMed ID: 10400746
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A.
He Y; Tan SL; Tareen SU; Vijaysri S; Langland JO; Jacobs BL; Katze MG
J Virol; 2001 Jun; 75(11):5090-8. PubMed ID: 11333890
[TBL] [Abstract][Full Text] [Related]
4. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance.
Gale MJ; Korth MJ; Katze MG
Clin Diagn Virol; 1998 Jul; 10(2-3):157-62. PubMed ID: 9741641
[TBL] [Abstract][Full Text] [Related]
5. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.
Gale M; Blakely CM; Kwieciszewski B; Tan SL; Dossett M; Tang NM; Korth MJ; Polyak SJ; Gretch DR; Katze MG
Mol Cell Biol; 1998 Sep; 18(9):5208-18. PubMed ID: 9710605
[TBL] [Abstract][Full Text] [Related]
6. GB virus type C NS5A sequence polymorphisms: association with interferon susceptibility and inhibition of PKR-mediated eIF2alpha phosphorylation.
Xiang J; Martinez-Smith C; Gale M; Chang Q; Labrecque DR; Schmidt WN; Stapleton JT
J Interferon Cytokine Res; 2005 May; 25(5):261-70. PubMed ID: 15871663
[TBL] [Abstract][Full Text] [Related]
7. High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.
Giménez-Barcons M; Franco S; Suárez Y; Forns X; Ampurdanès S; Puig-Basagoiti F; Sánchez-Fueyo A; Barrera JM; Llovet JM; Bruix J; Sánchez-Tapias JM; Rodés J; Saiz JC
Hepatology; 2001 Jul; 34(1):158-67. PubMed ID: 11431747
[TBL] [Abstract][Full Text] [Related]
8. Characterization and evolution of NS5A quasispecies of hepatitis C virus genotype 1b in patients with different stages of liver disease.
Franco S; Giménez-Barcons M; Puig-Basagoiti F; Furcic I; Sánchez-Tapias JM; Rodés J; Sáiz JC
J Med Virol; 2003 Oct; 71(2):195-204. PubMed ID: 12938193
[TBL] [Abstract][Full Text] [Related]
9. Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma.
De Mitri MS; Cassini R; Bagaglio S; Morsica G; Andreone P; Marino N; Bernardi M
Liver Int; 2007 Oct; 27(8):1126-33. PubMed ID: 17845542
[TBL] [Abstract][Full Text] [Related]
10. HCV NS5A co-operates with PKR in modulating HCV IRES-dependent translation.
Karamichali E; Foka P; Tsitoura E; Kalliampakou K; Kazazi D; Karayiannis P; Georgopoulou U; Mavromara P
Infect Genet Evol; 2014 Aug; 26():113-22. PubMed ID: 24815730
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma.
De Mitri MS; Morsica G; Cassini R; Bagaglio S; Zoli M; Alberti A; Bernardi M
J Hepatol; 2002 Jan; 36(1):116-22. PubMed ID: 11804673
[TBL] [Abstract][Full Text] [Related]
12. Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection.
Murphy MD; Rosen HR; Marousek GI; Chou S
Dig Dis Sci; 2002 Jun; 47(6):1195-205. PubMed ID: 12064791
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation.
George A; Panda S; Kudmulwar D; Chhatbar SP; Nayak SC; Krishnan HH
J Biol Chem; 2012 Feb; 287(7):5042-58. PubMed ID: 22184107
[TBL] [Abstract][Full Text] [Related]
14. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells.
Noguchi T; Satoh S; Noshi T; Hatada E; Fukuda R; Kawai A; Ikeda S; Hijikata M; Shimotohno K
Microbiol Immunol; 2001; 45(12):829-40. PubMed ID: 11838900
[TBL] [Abstract][Full Text] [Related]
15. Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma.
Hung CH; Chen CH; Lee CM; Wu CM; Hu TH; Wang JH; Yen YH; Lu SN
J Viral Hepat; 2008 Jan; 15(1):58-65. PubMed ID: 18088246
[TBL] [Abstract][Full Text] [Related]
16. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.
Gale MJ; Korth MJ; Tang NM; Tan SL; Hopkins DA; Dever TE; Polyak SJ; Gretch DR; Katze MG
Virology; 1997 Apr; 230(2):217-27. PubMed ID: 9143277
[TBL] [Abstract][Full Text] [Related]
17. Structural and molecular basis of interaction of HCV non-structural protein 5A with human casein kinase 1α and PKR.
Sudha G; Yamunadevi S; Tyagi N; Das S; Srinivasan N
BMC Struct Biol; 2012 Nov; 12():28. PubMed ID: 23148689
[TBL] [Abstract][Full Text] [Related]
18. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication.
Pflugheber J; Fredericksen B; Sumpter R; Wang C; Ware F; Sodora DL; Gale M
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4650-5. PubMed ID: 11904369
[TBL] [Abstract][Full Text] [Related]
19. PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone.
Rivas-Estilla AM; Svitkin Y; Lopez Lastra M; Hatzoglou M; Sherker A; Koromilas AE
J Virol; 2002 Nov; 76(21):10637-53. PubMed ID: 12368306
[TBL] [Abstract][Full Text] [Related]
20. Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner.
Podevin P; Sabile A; Gajardo R; Delhem N; Abadie A; Lozach PY; Beretta L; Bréchot C
Hepatology; 2001 Jun; 33(6):1503-11. PubMed ID: 11391540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
